海正药业：第三季度净利润为1.62亿元，同比增长102.14%

Core Viewpoint - Haizheng Pharmaceutical (600267) reported a revenue of 2.672 billion yuan for Q3 2025, reflecting a year-on-year growth of 1.57%, while net profit reached 162 million yuan, marking a significant increase of 102.14% [1] Financial Performance - Q3 revenue was 2.672 billion yuan, up 1.57% year-on-year [1] - Q3 net profit was 162 million yuan, showing a substantial increase of 102.14% year-on-year [1] - For the first three quarters, net profit totaled 461 million yuan, which represents a decline of 10.55% compared to the same period last year [1] Growth Drivers - The increase in net profit for the quarter is attributed to growth in sales of formulations and animal drugs, as well as cost reduction and efficiency improvements in production [1]